Development and investigation of a novel device with gemcitabine for hyperthermic intravesical chemotherapy

Development and investigation of a novel device with gemcitabine for hyperthermic intravesical chemotherapy

AbstractPurpose To evaluate the safety and efficacy of a novel hyperthermic intravesical chemotherapy (HIVEC) device in combination with gemcitabine.Materials and methods A pilot clinical trial was performed on patients with high-risk non-muscle invasive bladder cancer (NMIBC), who received HIVEC vi...

Full description

Bibliographic Details
Main Authors:	Li Jing, Chen Wenjian, Zhang Meimei, Chen Yanfei, Zhu Xuejin, Wang Bin
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Series:	International Journal of Hyperthermia
Subjects:	Bladder cancer hyperthermia intravesical chemotherapy gemcitabine recurrence
Online Access:	https://www.tandfonline.com/doi/10.1080/02656736.2022.2129103

Similar Items

A multi-institutional retrospective study of hyperthermic plus intravesical chemotherapy versus intravesical chemotherapy treatment alone in intermediate and high risk nonmuscle-invasive bladder cancer
by: Qiang Ruan, et al.
Published: (2021-02-01)

Case report: Gemcitabine intravesical hyperthermic infusion combined with tislelizumab in muscle invasive bladder urothelium carcinoma
by: Zheng Du, et al.
Published: (2022-12-01)

Safety and efficacy of intravesical chemotherapy and hyperthermia in the bladder: results of a porcine study
by: Wei Phin Tan, et al.
Published: (2020-01-01)

The Role of Adjuvant Single Postoperative Instillation of Gemcitabine for Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
by: Georgios Koimtzis, et al.
Published: (2022-05-01)

Short-term outcomes of intravesical gemcitabine for non-muscle-invasive bladder cancer after recent approval for use in Korea
by: Gang Kyu Kim, et al.
Published: (2024-09-01)

Intravesical Gemcitabine versus Intravesical Bacillus Calmette–Guérin for the Treatment of Non-Muscle Invasive Bladder Cancer: An Evaluation of Efficacy and Toxicity
by: Thiru Prasanna, et al.
Published: (2017-11-01)

Intravesical gemcitabine for non-muscle invasive bladder cancer: An abridged Cochrane Review
by: Mi Ah Han, et al.
Published: (2021-11-01)

Efficacy of intravesical gemcitabine instillation compared with intravesical Bacillus Calmette-Guérin instillation for non-muscle invasive bladder cancer
by: Dong Ha Kim, et al.
Published: (2024-12-01)

Co-Delivery of Cisplatin and Gemcitabine via Viscous Nanoemulsion for Potential Synergistic Intravesical Chemotherapy
by: Ting-Yu Chen, et al.
Published: (2020-10-01)

Gemcitabine hydrochloride microspheres used for intravesical treatment of superficial bladder cancer: a comprehensive in vitro/ex vivo/in vivo evaluation
by: Karavana SY, et al.
Published: (2018-07-01)

Impact of intravesical Bacillus Calmette-Guérin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer
by: Christopher James, et al.
Published: (2023-04-01)

3-year experience of hyperthermic intravesical chemotherapy use in patients with high risk non-muscular-invasive bladder cancer
by: R.S. Chystiakov, et al.
Published: (2023-06-01)

Complete response to intravesical gemcitabine in non‐muscle invasive bladder cancer patient after BCG failure: A case report and literature review
by: Fouad Nahhat, et al.
Published: (2022-09-01)

Evaluation of thermal dose effect in radiofrequency-induced hyperthermia with intravesical chemotherapy for nonmuscle invasive bladder cancer
by: Iris S. G. Brummelhuis, et al.
Published: (2023-12-01)

Intravesical therapy for urothelial carcinoma of the bladder
by: M Manoharan
Published: (2011-01-01)

Hyperthermic intravesical chemotherapy with mitomycin‐C for the treatment of high‐risk non‐muscle‐invasive bladder cancer patients
by: Samantha Conroy, et al.
Published: (2023-05-01)

Intravesical adriamycin in the management of bladder tumours Enugu experience
by: Aloy E Aghaji, et al.
Published: (1996-01-01)

The different predictive value of mean platelet volume-to-lymphocyte ratio for postoperative recurrence between non-muscular invasive bladder cancer patients treated with intravesical chemotherapy and intravesical chemohyperthermia
by: Chengbo Wang, et al.
Published: (2023-01-01)

The optimal intravesical maintenance chemotherapy scheme for the intermediate-risk group non-muscle-invasive bladder cancer
by: Jian-Xin Chen, et al.
Published: (2023-10-01)

Primary intravesical insertion of intrauterine device for 10 years: Clinical presentation and outcome
by: Rola Abu Alwafa, et al.
Published: (2024-03-01)

Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy
by: Vincenzo Serretta, et al.
Published: (2015-01-01)

The Safety, Tolerability, and Preliminary Efficacy of a Gemcitabine-releasing Intravesical System (TAR-200) in American Urological Association–defined Intermediate-risk Non–muscle-invasive Bladder Cancer Patients: A Phase 1b Study
by: F. Johannes P. van Valenberg, et al.
Published: (2024-04-01)

Efficacy of Intra-Arterial Plus Intravesical Chemotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer: A Pooled Analysis
by: Chunliang Cheng, et al.
Published: (2021-09-01)

The Efficacy of Intra-Arterial Plus Intravesical Chemotherapy Versus Intravesical Chemotherapy Alone After Bladder-Sparing Surgery in High-Risk Bladder Cancer: A Systematic Review and Meta-Analysis of Comparative Study
by: Zhongbao Zhou, et al.
Published: (2021-05-01)

Thermal Intravesical Chemotherapy Reduce Recurrence Rate for Non-muscle Invasive Bladder Cancer Patients: A Meta-Analysis
by: Kang Liu, et al.
Published: (2020-02-01)

Instillation Strategies for Non-Muscle-Invasive Bladder Cancer in the Bacillus Calmette-Guerin Shortage Era: A Simple Solution for BCG Discontinuation
by: Lin PT, et al.
Published: (2022-11-01)

A Hydrogel-Based Epirubicin Delivery System for Intravesical Chemotherapy
by: Ching-Wen Liu, et al.
Published: (2016-06-01)

Hyperthermia intravesical chemotherapy acts as a promising alternative to bacillus Calmette–Guérin instillation in non-muscle-invasive bladder cancer: a network meta-analysis
by: Na Zeng, et al.
Published: (2023-05-01)

Comparison of gemcitabine and anthracycline antibiotics in prevention of superficial bladder cancer recurrence
by: Tian-Wei Wang, et al.
Published: (2019-10-01)

Effectiveness of Neoadjuvant and Adjuvant Bladder Intracavitary Hyperthermic Perfusion Chemotherapy (BHPC) on High-risk Non-muscle-invasive Bladder Cancer Patients
by: LIU Sanhe, et al.
Published: (2019-03-01)

Application of intra-arterial chemotherapy in high-risk non-muscle invasive bladder cancer: a systematic review and meta-analysis
by: Chengyu You, et al.
Published: (2021-09-01)

Tumor cell dissociation‐enhanced intravesical chemotherapy of orthotopic bladder cancer
by: Zhaoyu Ma, et al.
Published: (2024-08-01)

The Use of Gemcitabine and Docetaxel as a Novel Combination for Hyperthermic Intraperitoneal Chemotherapy in the Management of Recurrent Complicated Abdominal Sarcoma: Case Report and Review of Literature
by: Ayman Zaki Azzam, et al.
Published: (2024-07-01)

Overnight Continuous Saline Bladder Irrigation After En Bloc Resection of Bladder Tumor Does Not Improve Oncological Outcomes in Patients Who Have Received Intravesical Chemotherapy
by: Yongjun Yang, et al.
Published: (2021-03-01)

Current Researches on Nanodrug Delivery Systems in Bladder Cancer Intravesical Chemotherapy
by: Yilei Lu, et al.
Published: (2022-05-01)

Intravesical chemotherapy synergize with an immune adjuvant by a thermo-sensitive hydrogel system for bladder cancer
by: J. Liu, et al.
Published: (2024-01-01)

Comparison of 3 and 4 cycles of neoadjuvant gemcitabine and cisplatin for muscle-invasive bladder cancer: a systematic review and meta-analysis
by: Lanpeng Lu, et al.
Published: (2023-11-01)

Safety Assessment of Ultrasound-Assisted Intravesical Chemotherapy in Normal Dogs: A Pilot Study
by: Noboru Sasaki, et al.
Published: (2022-03-01)

Novel intravesical therapeutics in the treatment of non-muscle invasive bladder cancer: Horizon scanning
by: Kelly Ward, et al.
Published: (2022-07-01)

A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma
by: Ma Yue, et al.
Published: (2011-03-01)